Investors

ChimaeraBio

ChimaeraBio (CB) is a life science specialist investment fund investing on behalf of the Reid family. The fund is managed by Jim and Karen Reid and it has been involved with a number of Scotland’s more successful life science companies including Haptogen (acquired by Wyeth), Qnostics (acquired by BBI plc) and D3 Technologies (acquired by Renishaw plc). CB was the lead funder in Sistemic and has supported the company from its seed round. CB currently has investments in a range of Scottish life science companies.

 

See www.chimaerabio.com for more.

 

Scottish Co investment Fund

The Scottish Investment Bank is the investment arm of Scottish Enterprise, operating Scotland-wide in partnership with Highlands and Islands Enterprise. It manages a suite of funds including the Scottish Seed Fund; the Scottish Co-investment Fund and the Scottish Venture Fund, which are partly funded by the European Regional Development Fund (ERDF); the Scottish Plastics Loan Fund and the Renewable Energy Investment Fund. SIB is also the cornerstone investor in the privately-managed Scottish Loan Fund and an investor in Rock Spring Venture’s Life Sciences Fund. These support Scotland’s SME funding market to ensure businesses with growth and export potential have adequate access to capital. SIB also provides a team of financial readiness specialists to help companies prepare for new investment and more easily access finance.

 

See www.scottish-enterprise.com/sib for more.

 

London & Scottish Investment Partners

London and Scottish Investment Partners is an exclusive group of Sophisticated Investors who invest in UK firms. Investors benefit from high quality deal-flow, a team of growth specialists dedicated to maximising shareholder value and a clear focus on taking the business to the next level and releasing this value. LSIP aim to invest up to £1million per case and to qualify for funding, companies will need to be well established (at least 2-3 years trading), solvent, have an existing revenue stream and have a route to exit or a liquidity event within 3 years. 

They must fall into Life Sciences, Technology, Oil & Gas, Food & Drink or Manufacturing sectors. LSIP aim to invest in Companies that would benefit from management expertise to release entrepreneurial value. Their team of Investors provide support, expertise and connections. Any investment is conditional on achieving an alignment with stakeholders and investors which permit strong management control, ongoing monitoring and support of the company. LSIP can invest in equity, loan, preference or convertible stock as well as purchasing existing equity meaning there is total flexibility in constructing the deal.

See www.lsip.co.uk for more.